Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
3.420
+0.110 (3.32%)
At close: Jun 26, 2026, 4:00 PM EDT
3.450
+0.030 (0.88%)
After-hours: Jun 26, 2026, 7:46 PM EDT
Niagen Bioscience Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Niagen Bioscience stock have an average target of 11.25, with a low estimate of 10 and a high estimate of 12. The average target predicts an increase of 228.95% from the current stock price of 3.42.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 28, 2026.
Analyst Ratings
The average analyst rating for Niagen Bioscience stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $10 | Buy | Maintains | $10 | +192.40% | May 28, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 → $11 | Buy | Reiterates | $12 → $11 | +221.64% | May 11, 2026 |
Unknown Analyst Ladenburg Thalmann & Co. No rating | Ladenburg Thalmann & Co. | Buy Reiterates $12 | Buy | Reiterates | $12 | +250.88% | May 7, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $13 → $12 | Buy | Reiterates | $13 → $12 | +250.88% | May 7, 2026 |
Financial Forecast
Revenue This Year
142.28M
from 129.42M
Increased by 9.94%
Revenue Next Year
166.92M
from 142.28M
Increased by 17.31%
EPS This Year
0.19
from 0.17
Increased by 13.50%
EPS Next Year
0.29
from 0.19
Increased by 52.63%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 144.6M | 173.9M | |
| Avg | 142.3M | 166.9M | |
| Low | 139.3M | 160.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.7% | 22.2% | |
| Avg | 9.9% | 17.3% | |
| Low | 7.6% | 12.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | 0.19 | 0.29 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | 13.5% | 52.6% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.